George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Too many shorts at play and looks like they are organising themselves not allowing this to rise..However, with good results, buy backs and share sale to i'm sure they will have to close their short positions soon..
Hey Sudnal....stung at the moment from BUR....but like you say hopeful it'll recover to give a return.
Hi c0dey....no no, in at around 21's and had been pleased to top up just under £18 over the last month...was looking for an under valued Brexit resistant share to cover losses from disastrous Aston Martin punt! Covered the losses (just) but looking at the results, buyback and bid talk was expecting the re-rate to be 26's and 27's ....hence the disappointment....still hopeful of 27's in a week. You?
Blimey over 300 posts since joining this month, you a full time blogger C0dey? However, agree not a share for an intra day trader with all those shorters desperate to get out as cheaply as possible and still not closed, but great for investors with a little patience. After all, twin threats of share buy-backs and acceptance of bids from competing two suitor deals that could drop anytime and the healthy fallback of increasing growth and falling debt for a dividend paying FTSE 100 company that is still very undervalued.
Good to see your apprehension has disappeared util
This should be up shortly and will give you handsome benefits. I see you are in BUR as well. Both are good choices as far as i can see, but just give it time.
Lost 23% on early trading.
Disappointed it hasn't stuck in the 26's or even 27's today. Profit taking for those who've bought in the 18's no doubt. Was always a winner at those prices. Hopefully it'll kick on this week and next. As the thread suggests markets filled with nerves and few hanging in for full value.
Nice summary on H&L site that neatly spells out why holders should not be in too much of a rush to take all their short term profits, plenty more to come.
NMC HEALTH SOARS ON DEAL SPECULATION; H1 PROFIT RISES
(Sharecast News) - NMC Health shares soared on Thursday following a report that two groups, including one backed by Chinese conglomerate Fosun, have made competing offers to buy a 40% stake in the UAE-based healthcare provider worth up to $1.9bn.
According to Reuters, the prospective purchasers are targeting a stake jointly owned by KBBO Group chairman, Khalifa Butti Bin Omeir, UAE-based businessman Saeed Bin Butti Al Qebaisi, and Infinite Investment, which was purchased for $1bn back in 2011.
Reuters cited two sources as saying that the group will pay a premium to NMC Health's market price for the target stake, though none of the parties have officially acknowledged a bid.
Also on Thursday, the FTSE 100 company unveiled plans to launch a $200m share buyback programme and said it remained on track to meet full-year targets after it achieved revenue of $1.2bn for the six months ended 30 June, up 33% compared to the same period last year.
The jump in revenue came as sales from the maternity & fertility division rose 44% to $164.5m following the acquisition of Boston IVF, while sales jumped by 34% to $696.0m at the multi-specialty & pharmacies division.
Pre-tax profit increased 18% to $140.6m.
NMC's chief executive, Prasanth Manghat, said the business is now well positioned to establish a dominant position in the attractive Saudi Arabia healthcare market after forming a "strategically important partnership" with GOSI/Hassana Investment Company.
At 1040 BST, the shares were up 27% to 2,455p.
Berenberg said that while both the results and the share buyback programme are good news in their own right, this is overshadowed by the deal speculation.
"If confirmed, this would be a substantial positive for the company, in our view, which could precipitate a material short squeeze," it said.
Russ Mould, investment director at AJ Bell, said: "Weak share prices across the UK stock market are providing plenty of opportunities for big investors to swoop on companies with depressed valuations. We've seen Greene King and Cobham receive bids from foreign companies in recent months, and over the past few years since the Brexit referendum other UK names have been snapped up by overseas bidders including Berendsen and ARM.
"There will no doubt be more deals if sterling remains very weak as Brexit has effectively made it hunting season for foreign companies who see value in depressed UK assets.
I am sure with broker upgrades coming in the next day to two, this will go higher..i guess it would touch £30 next week..
i guess this will close today in 2600-2800 range..
Gapped up today but capped at 2741 and has fallen down to 2451 now. It's early in the day though, but the initial increase is not bullish yet. Also resistance at the daily 200 EMA at 2591 is holding NMC back. Either way ,good news today and a possible reversal of its downtrend looks likely.
Where could this go guys
Good results 4 sure..lets go
Yep good results.
Excellent results today, Big investors trying to buy 40% stake + share buy back programme. Its going to rocket for the next few days..Expect 25-27 this week or next.
Nervous because been badly burnt on Metro and Aston Martin sold at £9.24 at took 2k.
Had these on t20 so couldn't take the risk after being 100k down on Metro
Stock Market is no place for nervous investors. Move all your money into a bank and earn your circa 1% interest or buy Premium Bonds if you want to be a tad more daring. For me, happy to be invested in a FTSE 100 company with a growing market, esp IVF (over 8 million IVF children have been born, and over 2.5 million cycles are being performed every year worldwide) and a dividend that is growing year on year and matches most bank rates.
Shall i hold what way do you see this going?